Akademisyen
ERDEM ÇUBUKÇU
PROFESÖR
BURSA ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 74
- Proje 0
- Kitap 0
- Bildiri 69
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
7
Q2
15
Q3
17
Q4
4
WoS (JCR)
Q1
3
Q2
5
Q3
9
Q4
25
TR Index
18
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
1
Üst %10 makale
1
Ort. yüzdelik
88.3%
Üst %1 payı
50.0%
Üst %10 payı
50.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2022 Why do some patients with stage 1A and 1B endometrial endometrioid carcinoma experience recurrence? A retrospective study in search of prognostic factors YÖKSİS SJR Q3 JCR Q4
- 2022 Trastuzumab\u2009±\u2009Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group YÖKSİS SJR Q3 JCR Q4
- 2021 Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer YÖKSİS SJR Q3 JCR Q4
- 2021 DPYD c.1905+1G>A Promotes Fluoropyrimidine-Driven Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer YÖKSİS SJR Q3 JCR Q4
- 2019 The efficacy and reliability of sequential adjuvant anthracyclinebasedchemotherapy and weekly paclitaxel regimen in humanepidermal growth factor receptor 2 negative breast cancer: Aretrospective analysis of a multicentre study YÖKSİS SJR Q3 JCR Q4
- 2019 The efficacy and reliability of sequential adjuvant anthracycline based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study YÖKSİS SJR Q3 JCR Q4
- 2015 Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis. YÖKSİS SJR Q3 JCR Q4
- 2015 Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy. YÖKSİS SJR Q3 JCR Q4
- 2015 Malignant melanoma of the stomach in an elderly patient YÖKSİS SJR Q3 JCR Q4
- 2015 Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. YÖKSİS SJR Q3 JCR Q4
- 2015 Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? YÖKSİS SJR Q3 JCR Q4
- 2014 Clinical significance of adiponectin expression in colon cancer patients YÖKSİS SJR Q3 JCR Q4
- 2014 Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer YÖKSİS SJR Q3 JCR Q4
- 2013 Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer YÖKSİS SJR Q3 JCR Q4
- 2013 A multi-institutional evaluation of carboplatin plus docetaxel combination in elderly patients with advanced gastric cancer YÖKSİS SJR Q3 JCR Q4
- 2012 Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors. YÖKSİS SJR Q3 JCR Q4
- 2011 The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey multicenter observational study. YÖKSİS SJR Q3 JCR Q4